| 1 |
Rello J, Valenzuela-Sánchez F, Ruiz-Rodriguez M, et al. Sepsis: a review of advances in management[J]. Adv Ther, 2017, 34 (11): 2393-2411.
|
| 2 |
Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study[J]. Lancet, 2020, 395 (10219): 200-211.
|
| 3 |
Zheng X, Chen W, Gong F, et al. The role and mechanism of pyroptosis and potential therapeutic targets in sepsis: a review[J]. Front Immunol, 2021, 12: 711939.
|
| 4 |
Zampieri FG, Bagshaw SM, Semler MW. Fluid therapy for critically ill adults with sepsis: a review[J]. JAMA, 2023, 329 (22): 1967-1980.
|
| 5 |
Barichello T, Generoso JS, Singer M, et al. Biomarkers for sepsis: more than just fever and leukocytosis—a narrative review[J]. Crit Care, 2022, 26 (1): 14.
|
| 6 |
Parlato M, Philippart F, Rouquette A, et al. Circulating biomarkers may be unable to detect infection at the early phase of sepsis in ICU patients: the CAPTAIN prospective multicenter cohort study[J]. Intensive Care Med, 2018, 44 (7): 1061-1070.
|
| 7 |
Li S, Rong H, Guo Q, et al. Serum procalcitonin levels distinguish Gram-negative bacterial sepsis from Gram-positive bacterial and fungal sepsis[J]. J Res Med Sci, 2016, 21: 39.
|
| 8 |
Pierrakos C, Velissaris D, Bisdorff M, et al. Biomarkers of sepsis: time for a reappraisal[J]. Crit Care, 2020, 24 (1): 287.
|
| 9 |
Póvoa P, Coelho L, Dal-Pizzol F, et al. How to use biomarkers of infection or sepsis at the bedside: guide to clinicians[J]. Intensive Care Med, 2023, 49 (2): 142-153.
|
| 10 |
Nylen ES, Whang KT, Snider RH Jr, et al. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis[J]. Crit Care Med, 1998, 26 (6): 1001-1006.
|
| 11 |
Al-Biltagi M, Hantash EM, El-Shanshory MR, et al. Plasma D-dimer level in early and late-onset neonatal sepsis[J]. World J Crit Care Med, 2022, 11 (3): 139-148.
|
| 12 |
Johnson ED, Schell JC, Rodgers GM. The D-dimer assay[J]. Am J Hematol, 2019, 94 (7): 833-839.
|
| 13 |
Deitcher SR, Eisenberg PR. Elevated concentrations of cross-linked fibrin degradation products in plasma. An early marker of gram-negative bacteremia[J]. Chest, 1993, 103 (4): 1107-1112.
|
| 14 |
Kinasewitz GT, Yan SB, Basson B, et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569][J]. Crit Care, 2004, 8 (2): R82-R90.
|
| 15 |
Goebel PJ, Williams JB, Gerhardt RT. A pilot study of the performance characteristics of the D-dimer in presumed sepsis[J]. West J Emerg Med, 2010, 11 (2): 173-179.
|
| 16 |
武宇辉，李成荣，何颜霞，等.脓毒症患儿血浆微RNA表达及其与炎症细胞因子的相关性[J].中华儿科杂志，2014，52（1）：28-33.
|
| 17 |
王婷，韦小碗，杨亮，等.脓毒症患者血清PCT、CRP、IL-6和IL-10水平检测及临床意义[J].陕西医学杂志，2020，49（11）：1510-1514.
|
| 18 |
樊柳汝，李金兰，李筱妍.脓毒症生物标志物研究进展[J].中国急救医学，2022，42（7）：620-624.
|
| 19 |
Gong Y, Yan X, Sun X, et al. Oncostatin M is a prognostic biomarker and inflammatory mediator for sepsis[J]. J Infect Dis, 2020, 221 (12): 1989-1998.
|
| 20 |
Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116 (2): 281-297.
|
| 21 |
Wang T, Xu S, Zhang L, et al. Identification of immune-related lncRNA in sepsis by construction of ceRNA network and integrating bioinformatic analysis[J]. BMC Genomics, 2023, 24 (1): 484.
|
| 22 |
Li L, Huang L, Huang C, et al. The multiomics landscape of serum exosomes during the development of sepsis[J]. J Adv Res, 2022, 39: 203-223.
|
| 23 |
Shi W, Zhu W, Yu J, et al. LncRNA HOTTIP as a diagnostic biomarker for acute respiratory distress syndrome in patients with sepsis and to predict the short-term clinical outcome: a case-control study[J]. BMC Anesthesiol, 2024, 24 (1): 30.
|
| 24 |
Hung SK, Lan HM, Han ST, et al. Current evidence and limitation of biomarkers for detecting sepsis and systemic infection[J]. Biomedicines, 2020, 8 (11): 494.
|
| 25 |
Kondo Y, Umemura Y, Hayashida K, et al. Diagnostic value of procalcitonin and presepsin for sepsis in critically ill adult patients: a systematic review and meta-analysis[J]. J Intensive Care, 2019, 7: 22.
|
| 26 |
Velissaris D, Zareifopoulos N, Karamouzos V, et al. Presepsin as a diagnostic and prognostic biomarker in sepsis[J]. Cureus, 2021, 13 (5): e15019.
|
| 27 |
Chang W, Peng F, Meng SS, et al. Diagnostic value of serum soluble triggering expressed receptor on myeloid cells 1 (sTREM-1) in suspected sepsis: a meta-analysis[J]. BMC Immunol, 2020, 21 (1): 2.
|
| 28 |
Wang HX, Chen B. Diagnostic role of soluble triggering receptor expressed on myeloid cell-1 in patients with sepsis[J]. World J Emerg Med, 2011, 2 (3): 190-194.
|
| 29 |
黄文辉，何轶群，李娟，等. sTREM-1、Presepsin对儿童脓毒症诊断和预后评估的价值[J].中国现代医学杂志，2021，31（19）：7-13.
|
| 30 |
Wu YL, Yo CH, Hsu WT, et al. Accuracy of heparin-binding protein in diagnosing sepsis: a systematic review and meta-analysis[J]. Crit Care Med, 2021, 49 (1): e80-e90.
|
| 31 |
Han X, Dou Q, Zhu Y, et al. Heparin-binding protein-enhanced quick SOFA score improves mortality prediction in sepsis patients[J]. Front Med (Lausanne), 2022, 9: 926798.
|
| 32 |
张浙恩，李煜堃，陈嘉安，等.中性粒细胞计数与淋巴细胞计数和血小板计数比值对脓毒症患者院内死亡风险的预测价值[J].浙江医学，2025，47（7）：712-716.
|
| 33 |
Xin Y, Shao Y, Mu W, et al. Accuracy of the neutrophil-to-lymphocyte ratio for the diagnosis of neonatal sepsis: a systematic review and meta-analysis[J]. BMJ Open, 2022, 12 (12): e060391.
|
| 34 |
Ye Z, Hu T, Wang J, et al. Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: a systematic review and meta-analysis[J]. Front Cardiovasc Med, 2022, 9: 933913.
|
| 35 |
Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma[J]. Clin Cancer Res, 2014, 20 (23): 6212-6222.
|
| 36 |
张玉霞，谢钦，魏思瑞，等.炎症及营养指标对老年食管鳞癌患者术后生存的预测价值[J].中华消化外科杂志，2024，23（9）：1200-1208.
|
| 37 |
Mangalesh S, Dudani S, Malik A. The systemic immune-inflammation index in predicting sepsis mortality[J]. Postgrad Med, 2023, 135 (4): 345-351.
|
| 38 |
Jiang D, Bian T, Shen Y, et al. Association between admission systemic immune-inflammation index and mortality in critically ill patients with sepsis: a retrospective cohort study based on MIMIC-IV database[J]. Clin Exp Med, 2023, 23 (7): 3641-3650.
|
| 39 |
Martin MD, Badovinac VP, Griffith TS. CD4 T cell responses and the sepsis-induced immunoparalysis state[J]. Front Immunol, 2020, 11: 1364.
|
| 40 |
Kühlhorn F, Rath M, Schmoeckel K, et al. Foxp3+ regulatory T cells are required for recovery from severe sepsis[J]. PLoS One, 2013, 8 (5): e65109.
|
| 41 |
张慧秋，刘丽，刘玲，等.外周血Th1/Th2、Treg/Th17细胞因子对重症脓毒症病人近期预后的预测价值[J].蚌埠医学院学报，2022，47（9）：1180-1184.
|